Premium
Serogroup C Neisseria meningitidis invasive infection: analysis of the possible vaccination strategies for a mass campaign
Author(s) -
Chiappini Elena,
Venturini Elisabetta,
Bonsignori Francesca,
Galli Luisa,
De Martino Maurizio
Publication year - 2010
Publication title -
acta pædiatrica
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.772
H-Index - 115
eISSN - 1651-2227
pISSN - 0803-5253
DOI - 10.1111/j.1651-2227.2010.01908.x
Subject(s) - medicine , neisseria meningitidis , vaccination , meningococcal vaccine , meningococcal disease , mass vaccination , vaccination schedule , schedule , conjugate vaccine , neisseriaceae , immunization , virology , pediatrics , immunology , microbiology and biotechnology , antibiotics , antigen , genetics , bacteria , computer science , biology , operating system
The serogroup C meningococcal conjugate vaccine is available since 1999. In the absence of randomized controlled trials that support a specific schedule, each country has adopted different vaccination programmes. Hereby, we analyse positive and negative aspects of the different vaccination strategies. Conclusion: While waiting for the introduction of other antimeningococcal vaccines, covering also for the Group B meningococci, further studies on effectiveness of an optimal schedule to be adopted in European countries are needed.